{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:15:06Z","timestamp":1788322506765,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Deep inspiration breath-hold (DIBH) is a radiotherapy standard technique for cardiac-sparing in breast cancer, particularly for left-sided tumors. However, not all patients can successfully complete DIBH RT in clinical routine, necessitating conversion to free breathing (FB) techniques and replanning. This study aimed to identify clinical factors predictive of DIBH feasibility to optimize patient selection and resource utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective study analyzed all patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091920) who underwent curative postoperative breast cancer radiotherapy at our institution between May 2020 and December 2024. All patients underwent initial DIBH feasibility assessment and were evaluated for completion of radiotherapy with DIBH or conversion to FB technique. A detailed subanalysis was performed for all patients treated in 2023 (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009470). Patient-related factors including age, body mass index (BMI), Karnofsky Performance Status (KPS), Charlson Comorbidity Index (CCI), pulmonary comorbidities, smoking status, and geometric surface distance between DIBH and FB planning scans were collected for the subanalysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Across the entire cohort (years 2020\u20132024) of 1,920 patients, 78 replannings (4%) occurred due to conversion from DIBH to free breathing. Increasing age (cut-off of 63 years) was significantly associated with higher replanning rates (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). In the 2023 subanalysis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009470), pulmonary comorbidities (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.008), higher CCI (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044), and a geometric surface distance of below 1\u00a0cm between DIBH and FB CT scans (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001) were significant predictors of replanning. The Karnofsky Performance Score, BMI, and smoking status showed no significant association with replanning.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Age, pulmonary comorbidities, overall comorbidity burden, and insufficient geometric displacement are significant predictors of DIBH failure in breast cancer radiotherapy. These readily available clinical parameters can optimize patient selection algorithms and inform decisions regarding dual CT simulation workflows. A risk-stratified approach incorporating these factors may reduce unnecessary imaging, decrease planning burden, and improve resource allocation while maintaining optimal cardiac protection for appropriate candidates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>\n                      The study was registered in the German Clinical Trials Register (DRKS; registration number: DRKS00038550) on 22 December 2025 (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.drks.de\/\" ext-link-type=\"uri\">https:\/\/www.drks.de\/<\/jats:ext-link>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-026-02919-5","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T15:06:50Z","timestamp":1788275210000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical evaluation using first-day assessment of patient suitability for successful performance of deep inspiration breath-hold for breast cancer radiotherapy"],"prefix":"10.1186","volume":"21","author":[{"given":"Bahar","family":"Cepni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Batista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Hoeltgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Waldsperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Wessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Liermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semi","family":"Harrabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weykamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Arians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Meixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"issue":"4","key":"2919_CR1","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31(4):1154\u201362.","journal-title":"Nat Med"},{"issue":"9804","key":"2919_CR2","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","volume":"378","author":"S Darby","year":"2011","unstructured":"Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011;378(9804):1707\u201316.","journal-title":"Lancet"},{"issue":"11","key":"2919_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987\u201398.","journal-title":"N Engl J Med"},{"key":"2919_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fonc.2018.00087","volume":"8","author":"C Bergom","year":"2018","unstructured":"Bergom C, Currey A, Desai N, Tai A, Strauss JB. Deep Inspiration Breath Hold: Techniques and Advantages for Cardiac Sparing During Breast Cancer Irradiation. Front Oncol. 2018;8:87.","journal-title":"Front Oncol"},{"key":"2919_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13014-015-0511-8","volume":"10","author":"R Yeung","year":"2015","unstructured":"Yeung R, Conroy L, Long K, Walrath D, Li H, Smith W, et al. Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation. Radiat Oncol. 2015;10:200.","journal-title":"Radiat Oncol"},{"issue":"3","key":"2919_CR6","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.prro.2014.08.003","volume":"5","author":"N Rochet","year":"2015","unstructured":"Rochet N, Drake JI, Harrington K, Wolfgang JA, Napolitano B, Sadek BT, et al. Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy: Evaluating cardiac contact distance as a predictor of cardiac exposure for patient selection. Pract Radiat Oncol. 2015;5(3):e127\u201334.","journal-title":"Pract Radiat Oncol"},{"issue":"1135","key":"2919_CR7","doi-asserted-by":"publisher","first-page":"20210295","DOI":"10.1259\/bjr.20210295","volume":"95","author":"C Schr\u00f6der","year":"2022","unstructured":"Schr\u00f6der C, Kirschke S, Blank E, Rohrberg S, F\u00f6rster R, Buchali A. Deep inspiration breath-hold for patients with left-sided breast cancer - A one-fits-all approach? A prospective analysis of patient selection using dosimetrical and practical aspects. Br J Radiol. 2022;95(1135):20210295.","journal-title":"Br J Radiol"},{"issue":"3","key":"2919_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/jrr\/rraa006","volume":"61","author":"R Yamauchi","year":"2020","unstructured":"Yamauchi R, Mizuno N, Itazawa T, Saitoh H, Kawamori J. Dosimetric evaluation of deep inspiration breath hold for left-sided breast cancer: analysis of patient-specific parameters related to heart dose reduction. J Radiat Res. 2020;61(3):447\u201356.","journal-title":"J Radiat Res"},{"key":"2919_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.radonc.2018.07.024","volume":"131","author":"C Simonetto","year":"2019","unstructured":"Simonetto C, Eidem\u00fcller M, Gaasch A, Pazos M, Sch\u00f6necker S, Reitz D, et al. Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol. 2019;131:202\u20137.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2919_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1756-9966-32-88","volume":"32","author":"V Bruzzaniti","year":"2013","unstructured":"Bruzzaniti V, Abate A, Pinnar\u00f2 P, D\u2019Andrea M, Infusino E, Landoni V, et al. Dosimetric and clinical advantages of deep inspiration breath-hold (DIBH) during radiotherapy of breast cancer. J Exp Clin Cancer Res. 2013;32(1):88.","journal-title":"J Exp Clin Cancer Res"},{"key":"2919_CR11","doi-asserted-by":"crossref","unstructured":"Mondal M, Mallik S, Goswami J. Deep inspiratory breath-hold technique for patients with left-sided breast cancer in resource-poor settings: Are there any patient selection criteria? Cancer Res Stat Treat. 2023;6(3).","DOI":"10.4103\/crst.crst_268_23"},{"issue":"5","key":"2919_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.21037\/gs-23-160","volume":"12","author":"H Zhu","year":"2023","unstructured":"Zhu H, Sun H, Zhang J, Xie Y, Jassem J, Franco P, et al. Cardiac exposure in left-sided breast cancer patients undergoing deep inspiratory breath hold radiation therapy. Gland Surg. 2023;12(5):677\u201386.","journal-title":"Gland Surg"},{"issue":"4","key":"2919_CR13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1754-9485.2012.02405.x","volume":"56","author":"AJ Hayden","year":"2012","unstructured":"Hayden AJ, Rains M, Tiver K. Deep inspiration breath hold technique reduces heart dose from radiotherapy for left-sided breast cancer. J Med Imaging Radiat Oncol. 2012;56(4):464\u201372.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"16","key":"2919_CR14","doi-asserted-by":"publisher","first-page":"7287","DOI":"10.3390\/app14167287","volume":"14","author":"E Hanczyk","year":"2024","unstructured":"Hanczyk E, Piecuch D, Kopcial S, Jonska-Gmyrek J. Factors Affecting the Effectiveness of DIBH (Deep Inspiratory Breath Hold) in Patients with Left Breast Cancer: A Narrative Review. Appl Sci [Internet]. 2024;14(16):7287.","journal-title":"Appl Sci [Internet]"},{"issue":"1","key":"2919_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2014.11.030","volume":"114","author":"BV Offersen","year":"2015","unstructured":"Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer. Radiother Oncol. 2015;114(1):3\u201310.","journal-title":"Radiother Oncol"},{"key":"2919_CR16","doi-asserted-by":"crossref","unstructured":"Sun X, Zhang Y, Wu XM, Zhou Y. Prediction models of cardiac sparing during deep inspiration breath-hold in left-sided breast cancer with internal mammary node irradiation. Int J Radiation Oncol Biol Phys. 2024.","DOI":"10.21203\/rs.3.rs-3972515\/v1"},{"key":"2919_CR17","volume-title":"Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancer","author":"A Linge","year":"2025","unstructured":"Linge A, Ketzmerick C, Gurtner K, Hoinkis C, L\u00f6ck S, Krause M. Development of a model to guide the decision for radiotherapy in deep-inspiration breath-hold in patients with left-sided breast cancer. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft [et al]; 2025."},{"key":"2919_CR18","doi-asserted-by":"crossref","unstructured":"Ga\u00e1l S, Kah\u00e1n Z, Paczona V, K\u00f3sz\u00f3 R, Drencs\u00e9nyi R, Szab\u00f3 J, et al. Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility. Radiat Oncol. 2021;16.","DOI":"10.1186\/s13014-021-01816-3"},{"issue":"5","key":"2919_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00520-025-09446-1","volume":"33","author":"AU Kefeli","year":"2025","unstructured":"Kefeli AU, Diremsizoglu U, Erdogan S, Karabey AU, Konuk AO, Tirpanci B, et al. Patient coaching for deep inspiration breath hold decreases set-up duration and left anterior descending artery dose for left-sided breast cancer radiotherapy. Support Care Cancer. 2025;33(5):387.","journal-title":"Support Care Cancer"},{"key":"2919_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.tipsro.2021.02.006","volume":"17","author":"S Ferdinand","year":"2021","unstructured":"Ferdinand S, Mondal M, Mallik S, Goswami J, Das S, Manir KS, et al. Dosimetric analysis of Deep Inspiratory Breath-hold technique (DIBH) in left-sided breast cancer radiotherapy and evaluation of pre-treatment predictors of cardiac doses for guiding patient selection for DIBH. Tech Innov Patient Support Radiat Oncol. 2021;17:25\u201331.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"2919_CR21","doi-asserted-by":"publisher","first-page":"100812","DOI":"10.1016\/j.ctro.2024.100812","volume":"48","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Xu J, Xu F, Li Y, Li H, Pan L, et al. Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT\/IMRT. Clin Translational Radiation Oncol. 2024;48:100812.","journal-title":"Clin Translational Radiation Oncol"},{"issue":"1","key":"2919_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13014-022-02002-9","volume":"17","author":"Y Koide","year":"2022","unstructured":"Koide Y, Shimizu H, Aoyama T, Kitagawa T, Miyauchi R, Watanabe Y, et al. Preoperative spirometry and BMI in deep inspiration breath-hold radiotherapy: the early detection of cardiac and lung dose predictors without radiation exposure. Radiat Oncol. 2022;17(1):35.","journal-title":"Radiat Oncol"},{"key":"2919_CR23","doi-asserted-by":"crossref","unstructured":"Busschaert SL, Kimpe E, Barb\u00e9 K, Gevaert T, De Ridder M, Putman K. Deep inspiration breath-hold for breast cancer radiotherapy: a modelling study of targeted versus non-targeted strategy for clinical and operational optimisation. Lancet Reg Health \u2013 Europe. 2026;60.","DOI":"10.1016\/j.lanepe.2025.101509"},{"issue":"4","key":"2919_CR24","first-page":"514","volume":"6","author":"S-L Busschaert","year":"2024","unstructured":"Busschaert S-L, Kimpe E, Gevaert T, De Ridder M, Putman K. Deep Inspiration Breath Hold in Left-Sided Breast Radiotherapy: A Balance Between Side Effects and Costs. JACC: CardioOncology. 2024;6(4):514\u201325.","journal-title":"JACC: CardioOncology"},{"key":"2919_CR25","volume-title":"Diagnostik, Therapie und Nachsorge des Mammakarzinoms \u2013 Langversion 5.0","author":"O Leitlinienprogramm","year":"2025","unstructured":"Leitlinienprogramm O, Fr\u00fcherkennung. Diagnostik, Therapie und Nachsorge des Mammakarzinoms \u2013 Langversion 5.0. Berlin: Leitlinienprogramm Onkologie; 2025."}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02919-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02919-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02919-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T03:30:20Z","timestamp":1788319820000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02919-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2919"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02919-5","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of the Medical Faculty of Heidelberg University (S535\/2025) and the requirement for informed consent was waived due to the retrospective nature of the analysis. The study was performed in compliance to the Helsinki Declaration in its current version.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Outside the submitted work, JHR received speaker fees from ViewRay Inc., Pfizer Inc., Accuray Sarl, Sanofi, and Astra Zeneca, as well as travel reimbursement from Varian Medical Systems and research grants from IntraOP Medical and Varian Medical Systems. F.W. received speaker fees from AstraZeneca, Varian Medical Systems, Siemens Healthineers, Chulabhorn Royal Academy, Klinikum Darmstadt and Merck Sharp & Dohme and travel support for attending meetings from AstraZeneca, Varian Medical Systems, Novocure GmbH, German Center for Lung Research (DZL), Fraunhofer MEVIS, Chulabhorn Royal Academy and Micropos Medical as well as compensation for advisory boards from Novocure GmbH and Merck Sharp & Dohme.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"119"}}